Clinical Trials Directory

Trials / Completed

CompletedNCT04339049

Comparative Efficacy of Lidocaine Spray Versus Vaginal Misoprostol in IUD Insertion

Comparative Efficacy of Lidocaine Spray Versus Vaginal Misoprostol in Reducing Pain During IUD Insertion in Adolescents and Nulliparous Women: a Randomized Controlled Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
147 (actual)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

the aim of the present study is to compare the safety and efficacy of lidocaine spray versus misoprostol in reducing pain during IUD insertion in adolescents and nulliparous women

Conditions

Interventions

TypeNameDescription
DRUGlidocaine sprayfour puffs (10 mg/puff) of lidocaine spray before tenaculum placement plus vaginal placebo 3 hours before IUD insertion
DRUGvaginal misoprostolvaginal misoprostol 200 mcg given 3 hours before IUD insertion plus four puffs of saline spray before tenaculum placement
DRUGplacebovaginal placebo given 3 hours before IUD insertion plus four puffs of saline spray before tenaculum placement

Timeline

Start date
2020-05-01
Primary completion
2021-07-17
Completion
2021-07-30
First posted
2020-04-08
Last updated
2021-12-10

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04339049. Inclusion in this directory is not an endorsement.

Comparative Efficacy of Lidocaine Spray Versus Vaginal Misoprostol in IUD Insertion (NCT04339049) · Clinical Trials Directory